@joshua/antibiotic-stewardship

Antibiotic stewardship

Author-made · not reviewedInfectious diseasesCC BY 4.0

Written by the BenchClub team with AI help. Answers follow public guidelines and textbooks; not yet reviewed by a practising physician.

v130 questionsUpdated Nov 18, 2026

Run it
  1. AMS-001Multiple choiceInfectious diseasesBasic

    A 28-year-old nonpregnant woman has had dysuria, urgency and frequency for 2 days. She has no fever, no flank pain and no costovertebral angle tenderness. Urinalysis shows 3+ leukocyte esterase and positive nitrite. She is otherwise healthy, has normal renal function, no drug allergies and no antibiotic exposure in the past 3 months. Local E. coli resistance is about 30% to trimethoprim-sulfamethoxazole and about 50% to fluoroquinolones. What is the preferred empiric treatment?

    1. ALevofloxacin 500 mg PO once daily for 3 days
    2. BTrimethoprim-sulfamethoxazole 160/800 mg PO twice daily for 3 days
    3. CNitrofurantoin monohydrate/macrocrystals 100 mg PO twice daily for 5 days
    4. DAmoxicillin 500 mg PO three times daily for 7 days
    5. ECeftriaxone 1 g IV once daily for 3 days
    Show answer

    Answer C

    Source IDSA/ESCMID 2010 International Clinical Practice Guidelines for Acute Uncomplicated Cystitis and Pyelonephritis in Women

  2. AMS-003Multiple choiceInfectious diseasesAdvanced

    A 68-year-old man with COPD is admitted to the ICU with severe community-acquired pneumonia: RR 32/min, PaO2/FiO2 210, and he requires norepinephrine. Eight months ago, sputum from a prior admission grew MRSA. He has not been hospitalized or received IV antibiotics in the past 90 days and has never had Pseudomonas isolated. Per the 2019 ATS/IDSA guideline, the most appropriate initial empiric regimen is:

    1. ACeftriaxone plus azithromycin; add MRSA coverage only if sputum grows MRSA
    2. BCeftriaxone plus azithromycin plus vancomycin (or linezolid)
    3. CMeropenem plus vancomycin plus azithromycin
    4. DPiperacillin-tazobactam plus vancomycin
    5. ELinezolid monotherapy
    Show answer

    Answer B

    Source 2019 ATS/IDSA Guideline for Diagnosis and Treatment of Adults with Community-acquired Pneumonia

  3. AMS-004Multiple choiceInfectious diseasesIntermediate

    A 58-year-old man has had fever and a cough productive of purulent sputum for 2 days. Chest CT shows left lower lobe consolidation. WBC 13,500/µL, procalcitonin 0.06 ng/mL. T 101.3°F (38.5°C), HR 96/min, RR 20/min, BP 132/80 mmHg, SpO2 95% on room air; he is admitted to a general ward. Per the 2019 ATS/IDSA guideline, which antibiotic decision is correct?

    1. AProcalcitonin <0.1 ng/mL indicates a viral infection; withhold antibiotics
    2. BHold antibiotics, repeat procalcitonin in 6-12 hours and start only if >0.25 ng/mL
    3. CAntibiotics are needed only if procalcitonin is >0.5 ng/mL
    4. DStart empiric antibiotic therapy for CAP now
    5. ESend a respiratory viral PCR panel and start antibiotics only if it is negative
    Show answer

    Answer D

    Source 2019 ATS/IDSA Guideline for Diagnosis and Treatment of Adults with Community-acquired Pneumonia

  4. AMS-005Multiple choiceInfectious diseasesIntermediate

    A 66-year-old woman received IV ceftriaxone for 7 days for cellulitis. Three days after stopping, she develops 6-8 watery stools per day. Stool C. difficile toxin is positive. T 100.0°F (37.8°C), WBC 12,000/µL, serum creatinine 0.9 mg/dL, normal blood pressure, no abdominal distension or ileus. This is her first episode. Per the 2021 IDSA/SHEA focused update, the preferred treatment is:

    1. AMetronidazole 500 mg PO three times daily for 10 days
    2. BVancomycin 500 mg IV every 12 hours
    3. CFidaxomicin 200 mg PO twice daily for 10 days
    4. DVancomycin 500 mg PO four times daily plus metronidazole 500 mg IV every 8 hours
    5. ELoperamide plus a probiotic, without antibiotics
    Show answer

    Answer C

    Source 2021 IDSA/SHEA Focused Update Guideline on Management of Clostridioides difficile Infection in Adults

  5. AMS-006Multiple choiceInfectious diseasesIntermediate

    A 55-year-old man with type 2 diabetes is admitted with a PICC-associated bloodstream infection and started on empiric vancomycin. Both admission blood culture sets grow Staphylococcus aureus; at 48 hours it is reported oxacillin-susceptible (MSSA). The PICC has been removed, repeat blood cultures are negative, and transthoracic echocardiography shows no vegetation. Renal function is normal and he has no penicillin allergy. The next antibiotic step is:

    1. AContinue vancomycin with AUC-guided dosing to avoid failure from switching
    2. BSwitch to cefazolin 2 g IV every 8 hours
    3. CSwitch to daptomycin 6 mg/kg once daily
    4. DAdd gentamicin to vancomycin for 3-5 days
    Show answer

    Answer B

    Source IDSA 2009 Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection; 2015 AHA Scientific Statement on Infective Endocarditis in Adults

  6. AMS-007Multiple choiceInfectious diseasesIntermediate

    A 70-year-old man with acute cholangitis is hemodynamically stable after ERCP drainage; serum creatinine is normal. Two blood culture sets grow ESBL-producing E. coli: resistant to ciprofloxacin and trimethoprim-sulfamethoxazole; susceptible to piperacillin-tazobactam (MIC 8 µg/mL), meropenem, ertapenem and amikacin. He has been on empiric piperacillin-tazobactam and his fever is resolving. Serum albumin 3.6 g/dL. Per IDSA 2024 AMR Guidance, the most appropriate definitive therapy is:

    1. ASwitch to ertapenem 1 g IV once daily
    2. BContinue piperacillin-tazobactam because it is susceptible in vitro and he is improving
    3. CSwitch to cefepime 2 g IV every 8 hours
    4. DAdd amikacin to piperacillin-tazobactam
    5. ESwitch to ceftazidime-avibactam
    Show answer

    Answer A

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  7. AMS-008Multiple choiceInfectious diseasesAdvanced

    A 64-year-old ICU patient with normal renal function has a catheter-related bloodstream infection (catheter removed). Blood cultures grow carbapenem-resistant Klebsiella pneumoniae. Carbapenemase testing: KPC positive; NDM and OXA-48 negative. The isolate is susceptible to ceftazidime-avibactam. Per IDSA 2024 AMR Guidance, which is a preferred regimen?

    1. APolymyxin B plus high-dose extended-infusion meropenem
    2. BTigecycline 100 mg loading dose, then 50 mg every 12 hours
    3. CAztreonam 2 g every 8 hours
    4. DMeropenem 2 g every 8 hours as a 3-hour extended infusion
    5. ECeftazidime-avibactam 2.5 g IV every 8 hours, each dose infused over 3 hours
    Show answer

    Answer E

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  8. AMS-009Multiple choiceInfectious diseasesAdvanced

    A 59-year-old liver transplant recipient has an intra-abdominal infection with bacteremia. Blood cultures grow carbapenem-resistant Klebsiella pneumoniae; carbapenemase testing is NDM positive, KPC negative. Per IDSA 2024 AMR Guidance, which of the following is preferred?

    1. ACeftazidime-avibactam monotherapy
    2. BMeropenem-vaborbactam
    3. CImipenem-cilastatin-relebactam
    4. DCeftazidime-avibactam plus aztreonam, infused simultaneously
    5. ETigecycline plus polymyxin B
    Show answer

    Answer D

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  9. AMS-010Multiple choiceInfectious diseasesIntermediate

    A 45-year-old woman is scheduled for elective laparoscopic cholecystectomy 3 weeks after an episode of acute cholecystitis and needs perioperative prophylaxis. She reports a generalized maculopapular rash after oral penicillin about 30 years ago as a child, with no dyspnea, angioedema, hypotension, skin desquamation or mucosal involvement. She has not received a beta-lactam since. Per the 2022 AAAAI/ACAAI practice parameter, the most appropriate approach is:

    1. AGive cefazolin directly, without prior skin testing or graded challenge
    2. BUse vancomycin plus gentamicin instead
    3. CUse clindamycin instead
    4. DPerform penicillin skin testing first and give cefazolin only if negative
    5. EDesensitize to cefazolin before giving it
    Show answer

    Answer A

    Source 2022 AAAAI/ACAAI Drug Allergy: A 2022 Practice Parameter Update

  10. AMS-011Multiple choiceInfectious diseasesBasic

    A 56-year-old 70-kg man is undergoing elective open inguinal hernia repair with mesh, expected to last 90 minutes. He has no drug allergies. If antibiotic prophylaxis is given, which approach is correct?

    1. ACefazolin 1 g on the ward 2-3 hours before surgery, continued for 3 days postoperatively
    2. BCeftriaxone 2 g before incision, then once daily for 3 days
    3. CCefazolin 2 g IV within 60 minutes before incision, as a single dose with no postoperative doses
    4. DA single dose of cefazolin 2 g after wound closure
    5. ELevofloxacin 500 mg PO before surgery, continued for 24 hours postoperatively
    Show answer

    Answer C

    Source 2013 ASHP/IDSA/SIS/SHEA Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

  11. AMS-013Multiple choiceInfectious diseasesAdvanced

    A 60-year-old man on day 7 of mechanical ventilation develops a new infiltrate, purulent secretions and T 102.0°F (38.9°C), and requires norepinephrine. Three weeks ago he received IV piperacillin-tazobactam for 10 days for an intra-abdominal infection. In this ICU, 25% of S. aureus isolates are MRSA and >10% of gram-negative isolates are resistant to any single antipseudomonal agent. Per the 2016 IDSA/ATS HAP/VAP guideline, the most appropriate initial empiric regimen is:

    1. AVancomycin plus cefepime plus levofloxacin
    2. BPiperacillin-tazobactam plus vancomycin
    3. CMeropenem plus cefepime plus vancomycin
    4. DCeftriaxone plus azithromycin
    5. EMeropenem monotherapy
    Show answer

    Answer A

    Source 2016 IDSA/ATS Guideline for Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia

  12. AMS-014Multiple choiceInfectious diseasesIntermediate

    A 48-year-old woman is on day 10 after induction chemotherapy for AML. ANC 100/µL, with neutropenia expected to last >7 days. T 101.5°F (38.6°C), BP 118/70 mmHg, HR 102/min. No cough, chest CT without infiltrates, no erythema or drainage at her port site, mild (grade 1) oral mucositis, no diarrhea. Normal renal function, no fluoroquinolone prophylaxis, no history of MRSA colonization or resistant organisms, no known drug allergies. After blood cultures are drawn, the most appropriate initial empiric therapy is:

    1. ACefepime plus vancomycin because she has a port
    2. BOral ciprofloxacin plus amoxicillin-clavulanate as an outpatient
    3. CCefepime 2 g IV every 8 hours as monotherapy
    4. DMeropenem plus vancomycin plus caspofungin
    5. ECeftriaxone 2 g IV daily
    Show answer

    Answer C

    Source IDSA 2010 Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer; 2018 ASCO/IDSA Outpatient Management of Fever and Neutropenia Guideline

  13. AMS-015Multiple choiceInfectious diseasesAdvanced

    A previously healthy 62-year-old man has had fever and headache for 1 day. In the emergency department: T 103.0°F (39.4°C), nuchal rigidity, drowsy and disoriented (GCS 13), no focal neurologic deficits, no papilledema. Per the IDSA 2004 bacterial meningitis guideline, the most appropriate sequence is:

    1. AHead CT, then lumbar puncture, then start antibiotics based on the CSF Gram stain
    2. BBlood cultures immediately, then dexamethasone 0.15 mg/kg plus vancomycin plus ceftriaxone plus ampicillin, then head CT, then lumbar puncture
    3. CBlood cultures, then vancomycin plus ceftriaxone, then immediate lumbar puncture without CT
    4. DBlood cultures, then meropenem monotherapy, then head CT, then lumbar puncture
    5. EImmediate lumbar puncture; add dexamethasone once the CSF confirms bacterial meningitis
    Show answer

    Answer B

    Source IDSA 2004 Practice Guidelines for the Management of Bacterial Meningitis

  14. AMS-016Multiple choiceInfectious diseasesBasic

    A 24-year-old 70-kg man has had purulent urethral discharge for 3 days. A Gram stain of the discharge shows gram-negative intracellular diplococci; chlamydia NAAT is pending. He has no drug allergies. Per the CDC 2021 STI treatment guidelines, the recommended regimen is:

    1. ACeftriaxone 500 mg IM once plus doxycycline 100 mg PO twice daily for 7 days
    2. BCeftriaxone 250 mg IM once plus azithromycin 1 g PO once
    3. CCiprofloxacin 500 mg PO once
    4. DCefixime 400 mg PO once plus azithromycin 1 g PO once
    5. EAzithromycin 2 g PO once
    Show answer

    Answer A

    Source CDC Sexually Transmitted Infections Treatment Guidelines, 2021

  15. AMS-017Multiple choiceInfectious diseasesIntermediate

    A 70-year-old man develops necrotizing pneumonia after influenza; sputum and blood cultures grow MRSA. Serum creatinine is normal. Because of recent chemotherapy for lymphoma his platelet count is 60,000/µL, and he takes sertraline long term. Which anti-MRSA agent is most appropriate?

    1. ALinezolid
    2. BDaptomycin 6 mg/kg once daily
    3. CTigecycline
    4. DCefazolin
    5. EVancomycin with AUC-guided dosing
    Show answer

    Answer E

    Source IDSA 2011 Clinical Practice Guidelines for the Treatment of MRSA Infections; 2019 ATS/IDSA Guideline for Diagnosis and Treatment of Adults with Community-acquired Pneumonia; 2020 ASHP/IDSA/PIDS/SIDP Consensus Guideline on Therapeutic Monitoring of Vancomycin for Serious MRSA Infections

  16. AMS-018Multiple choiceInfectious diseasesIntermediate

    A 68-year-old ICU patient has a catheter-related bloodstream infection; the catheter has been removed. Two blood culture sets grow Enterobacter cloacae complex: ceftriaxone S (MIC ≤1 µg/mL), cefepime S (MIC ≤1 µg/mL), piperacillin-tazobactam S, meropenem S, amikacin S. He is hemodynamically stable with normal renal function. Per IDSA 2024 AMR Guidance, the most appropriate definitive therapy is:

    1. ACeftriaxone 2 g IV daily
    2. BPiperacillin-tazobactam 4.5 g IV every 6 hours
    3. CCefepime 2 g IV every 8 hours
    4. DMeropenem 1 g IV every 8 hours
    5. ECeftazidime-avibactam 2.5 g IV every 8 hours
    Show answer

    Answer C

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  17. AMS-019Multiple choiceInfectious diseasesAdvanced

    A 71-year-old man develops ventilator-associated pneumonia on day 9 of mechanical ventilation. A quality lower respiratory specimen and blood cultures grow carbapenem-resistant Acinetobacter baumannii (CRAB), susceptible to sulbactam-durlobactam, polymyxin B MIC ≤2 µg/mL, minocycline intermediate. Renal function is normal. Per IDSA 2024 AMR Guidance, the preferred regimen is:

    1. APolymyxin B monotherapy
    2. BCefiderocol monotherapy
    3. CHigh-dose tigecycline monotherapy
    4. DHigh-dose extended-infusion meropenem plus rifampin
    5. ESulbactam-durlobactam plus imipenem-cilastatin
    Show answer

    Answer E

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  18. AMS-020Multiple choiceInfectious diseasesAdvanced

    A 63-year-old woman on day 12 of mechanical ventilation has ventilator-associated pneumonia with septic shock. Quantitative bronchoalveolar lavage culture grows Stenotrophomonas maltophilia at ≥10^4 CFU/mL, susceptible to trimethoprim-sulfamethoxazole, minocycline and levofloxacin. She is not neutropenic, renal function is normal and she has no sulfa allergy. Per IDSA 2024 AMR Guidance, the most appropriate regimen is:

    1. ATrimethoprim-sulfamethoxazole monotherapy for 14 days
    2. BTrimethoprim-sulfamethoxazole plus minocycline, with step-down to monotherapy considered after clinical improvement
    3. CLevofloxacin monotherapy
    4. DCeftazidime monotherapy
    5. EMeropenem plus amikacin
    Show answer

    Answer B

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  19. AMS-021Multiple choiceInfectious diseasesAdvanced

    A 57-year-old man has hospital-acquired pneumonia. Sputum and blood cultures grow Pseudomonas aeruginosa: meropenem R, imipenem R (carbapenemase testing negative); cefepime S (MIC 4 µg/mL), piperacillin-tazobactam S, ceftazidime-avibactam S, ceftolozane-tazobactam S. Renal function is normal. Per IDSA 2024 AMR Guidance, the most appropriate definitive therapy is:

    1. ACefepime 2 g every 8 hours as an extended (3-hour) infusion
    2. BCeftolozane-tazobactam 3 g every 8 hours
    3. CCeftazidime-avibactam 2.5 g every 8 hours
    4. DPolymyxin B plus high-dose meropenem
    5. ECefiderocol 2 g every 8 hours
    Show answer

    Answer A

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  20. AMS-022Multiple choiceInfectious diseasesBasic

    None of the following patients has urinary symptoms, and each urine culture grows a single organism at ≥10^5 CFU/mL. Per the IDSA 2019 asymptomatic bacteriuria guideline, which patient should receive antibiotic treatment for the bacteriuria?

    1. AA 52-year-old woman with type 2 diabetes, HbA1c 8.5%
    2. BA 35-year-old man with spinal cord injury who uses intermittent catheterization
    3. CA 48-year-old man 6 months after kidney transplantation
    4. DA 76-year-old man scheduled for transurethral resection of the prostate (TURP)
    5. EAn 80-year-old woman with a long-term indwelling urinary catheter
    Show answer

    Answer D

    Source IDSA 2019 Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria

  21. AMS-023Multiple choiceInfectious diseasesIntermediate

    A 45-year-old woman has acute pyelonephritis, T 101.5°F (38.6°C), normal blood pressure and renal function, is not pregnant, has no drug allergies, tolerates oral intake and is to be treated as an outpatient. Urine culture grows ESBL-producing E. coli: resistant to ciprofloxacin, levofloxacin, trimethoprim-sulfamethoxazole and amoxicillin-clavulanate; susceptible to ertapenem, amikacin, nitrofurantoin and fosfomycin. Per IDSA 2024 AMR Guidance, the most appropriate regimen is:

    1. ANitrofurantoin 100 mg PO twice daily
    2. BFosfomycin tromethamine 3 g PO once
    3. CCefixime 400 mg PO daily
    4. DErtapenem 1 g IV once daily (outpatient parenteral therapy)
    5. EHigh-dose oral amoxicillin-clavulanate
    Show answer

    Answer D

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  22. AMS-031Multiple choiceInfectious diseasesAdvanced

    A 74-year-old man has native mitral valve endocarditis with a 9-mm vegetation on TEE. Blood cultures grow Enterococcus faecalis: ampicillin susceptible (MIC 1 µg/mL), vancomycin susceptible, with high-level resistance to both gentamicin and streptomycin. Creatinine clearance 85 mL/min. He has no penicillin allergy and no indication for urgent surgery. Per the 2015 AHA scientific statement, the most appropriate antibiotic regimen is:

    1. AAmpicillin plus gentamicin 1 mg/kg IV every 8 hours for 4-6 weeks
    2. BCeftriaxone 2 g IV every 12 hours as monotherapy for 6 weeks
    3. CVancomycin plus gentamicin for 6 weeks
    4. DAmpicillin 2 g IV every 4 hours plus ceftriaxone 2 g IV every 12 hours for 6 weeks
    5. EAmpicillin plus streptomycin 15 mg/kg/day IV for 4-6 weeks
    Show answer

    Answer D

    Source 2015 AHA Scientific Statement on Infective Endocarditis in Adults (Baddour et al.); 2023 ESC Guidelines for the Management of Endocarditis

  23. AMS-032Multiple choiceInfectious diseasesIntermediate

    A 62-year-old woman was admitted with pyelonephritis and bacteremia. Blood and urine cultures grow ESBL-producing E. coli: resistant to ceftriaxone, ciprofloxacin, levofloxacin and amoxicillin-clavulanate; susceptible to trimethoprim-sulfamethoxazole, nitrofurantoin, fosfomycin, ertapenem and meropenem. After 3 days of meropenem she is afebrile and hemodynamically stable, imaging shows no obstruction or abscess, repeat blood cultures are negative and she tolerates oral intake with normal GI absorption. Normal renal function, no drug allergies, not pregnant. Per IDSA 2024 AMR Guidance, the most appropriate next step is:

    1. ASwitch to oral nitrofurantoin 100 mg twice daily to complete the course
    2. BSwitch to a single dose of oral fosfomycin 3 g
    3. CSwitch to oral trimethoprim-sulfamethoxazole 160/800 mg PO twice daily to complete the course
    4. DContinue IV meropenem for the full course, because ESBL bacteremia requires a carbapenem throughout
    5. EPlace a PICC and switch to ertapenem 1 g IV daily for 14 days
    Show answer

    Answer C

    Source IDSA 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (AMR Guidance 4.0)

  24. AMS-024Short answerInfectious diseasesAdvanced

    A 63-year-old man with type 2 diabetes has had fever for 4 days with progressively worsening back pain. Both admission blood culture sets grow MRSA, vancomycin MIC 1 µg/mL, and he is on vancomycin (estimated AUC about 450 mg·h/L). He has no intravascular catheter, prosthetic valve or implanted device. On day 3, repeat blood cultures are still positive; transthoracic echocardiography shows no vegetation. Outline the next steps: further workup, principles for adjusting antibiotics, and duration of therapy.

    Rubric

    • +2States blood cultures should be repeated until negative, with duration counted from the first negative culture
    • +2Calls for transesophageal echocardiography
    • +2Orders spine MRI for back pain to evaluate vertebral osteomyelitis/epidural abscess
    • +2Emphasizes source control and adequate vancomycin exposure, with a switch to high-dose daptomycin (8-10 mg/kg) or combination therapy if bacteremia continues
    • +2Classifies this as complicated bacteremia requiring at least 4-6 weeks (longer for osteomyelitis)
    • +1Recommends infectious diseases consultation
    • -3Treats with an uncomplicated-bacteremia course of 14 days or less, or switches to oral therapy before blood cultures clear and metastatic foci are evaluated
    • -3Treats the S. aureus blood culture as a contaminant
    Show answer

    Reference answer S. aureus in blood culture is always treated as true bacteremia. (1) Obtain infectious diseases consultation; repeat blood cultures every 24-48 hours until negative and count duration from the first negative culture. (2) Transesophageal echocardiography - a negative TTE does not exclude endocarditis. (3) Back pain needs contrast MRI of the spine to look for vertebral osteomyelitis/epidural abscess; search for and treat other metastatic foci and drain abscesses (source control). (4) Persistent bacteremia (often defined as positive cultures for ≥3-5 days on active therapy): first find and control the source and confirm vancomycin exposure is adequate - continuing optimized vancomycin while the source is pursued is acceptable at day 3; if bacteremia persists despite target AUC, consider switching to high-dose daptomycin (8-10 mg/kg/day); salvage options include daptomycin plus a beta-lactam such as ceftaroline. (5) Duration: this is complicated bacteremia (persistent positivity, likely metastatic focus) - at least 4-6 weeks, and at least 8 weeks if MRSA vertebral osteomyelitis is confirmed; it must not be treated as 14-day uncomplicated bacteremia. Once bacteremia has cleared, metastatic foci are controlled and the patient is stable, selected patients may be switched under ID guidance to a highly bioavailable oral agent (OVIVA; POET excluded MRSA), but not before blood cultures clear and the workup is complete.

    Source IDSA 2011 Clinical Practice Guidelines for the Treatment of MRSA Infections; 2020 ASHP/IDSA/PIDS/SIDP Consensus Guideline on Therapeutic Monitoring of Vancomycin for Serious MRSA Infections; 2015 AHA Scientific Statement on Infective Endocarditis in Adults; 2023 ESC Guidelines for the Management of Endocarditis; IDSA 2015 Native Vertebral Osteomyelitis Guideline

  25. AMS-025Short answerInfectious diseasesIntermediate

    A 58-year-old woman weighing 125 kg (276 lb) is scheduled for elective laparoscopic right hemicolectomy, expected to last 5 hours. She has no drug allergies and normal renal function. Using the cefazolin plus metronidazole regimen recommended by the 2013 ASHP/IDSA/SIS/SHEA surgical prophylaxis guideline, write the IV prophylaxis plan: drugs and doses, timing, intraoperative redosing and when to stop.

    Rubric

    • +2Chooses cefazolin plus metronidazole 500 mg IV
    • +2Uses cefazolin 3 g for weight ≥120 kg
    • +2Starts within 60 minutes before incision
    • +2States cefazolin 3 g is redosed 4 hours after the preoperative dose during this 5-hour case (and for blood loss >1500 mL)
    • +2Stops prophylaxis at wound closure or within 24 hours (no postoperative doses needed)
    • -3Continues prophylaxis beyond 24 hours postoperatively
    • -2Uses cefazolin alone without anaerobic coverage
    Show answer

    Reference answer Colorectal surgery needs coverage of enteric gram-negative bacilli and anaerobes: cefazolin plus metronidazole. For weight ≥120 kg, cefazolin is 3 g; metronidazole 500 mg. Start within 60 minutes before incision. Cefazolin is redosed every 4 hours timed from the preoperative dose (so if surgery is still under way 4 hours after the first dose, give another 3 g; also redose for blood loss >1500 mL); metronidazole generally does not need redosing within this duration. No postoperative doses are needed - stop within 24 hours at most, and stopping at wound closure is acceptable. Oral antibiotic bowel preparation may be combined.

    Source 2013 ASHP/IDSA/SIS/SHEA Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

  26. AMS-026Short answerInfectious diseasesIntermediate

    A 66-year-old woman on ICU day 12 has a central venous catheter and is receiving parenteral nutrition. She develops a new fever; 2 blood culture sets grow yeast, later identified as Candida albicans (susceptibilities pending). She is hemodynamically stable and not neutropenic. Outline management: initial drug, catheter management, required examinations, timing of step-down and duration.

    Rubric

    • +2Starts an echinocandin at a correct dose
    • +2Removes the central venous catheter
    • +1Repeats blood cultures until negative
    • +2Orders a dilated fundoscopic exam to exclude endophthalmitis
    • +2Treats for 14 days after the first negative blood culture and symptom resolution
    • +2Steps down to fluconazole 400 mg daily, usually within 5-7 days, when stable, cleared and fluconazole-susceptible
    • -3Treats Candida in blood cultures as a contaminant and does not treat
    • -2Uses defervescence instead of 14 days after the first negative culture as the endpoint
    Show answer

    Reference answer (1) Start an echinocandin: caspofungin 70 mg loading dose then 50 mg daily (or micafungin 100 mg daily, or anidulafungin 200 mg loading dose then 100 mg daily; rezafungin 400 mg once then 200 mg weekly is also acceptable). (2) Remove the central venous catheter as early as possible. (3) Repeat blood cultures daily or every other day until negative. (4) In non-neutropenic patients, a dilated fundoscopic exam by an ophthalmologist within the first week to exclude Candida endophthalmitis; echocardiography if candidemia persists. (5) When clinically stable, cultures have cleared and the isolate is fluconazole-susceptible, step down to fluconazole 400 mg daily (6 mg/kg, renally adjusted, no reload) usually within 5-7 days. (6) Without metastatic complications, treat for 14 days after the first negative blood culture and resolution of symptoms.

    Source IDSA 2016 Clinical Practice Guideline for the Management of Candidiasis

  27. AMS-027Short answerInfectious diseasesIntermediate

    A 72-year-old man has non-ventilator hospital-acquired pneumonia and is on empiric vancomycin plus piperacillin-tazobactam. On day 3 he has been afebrile for 36 hours, oxygenation has improved and blood cultures are negative. A quality sputum culture grows Haemophilus influenzae (beta-lactamase positive, ampicillin-resistant, susceptible to amoxicillin-clavulanate and ceftriaxone); no other organisms are isolated. Nasal MRSA PCR is negative. Renal function is normal, he has no drug allergies and can take oral medications. Write the antibiotic adjustment and total duration.

    Rubric

    • +2Stops vancomycin and gives the reason (negative MRSA PCR / no MRSA in culture)
    • +3Stops piperacillin-tazobactam and de-escalates to a narrow agent active against beta-lactamase-positive H. influenzae (e.g., ceftriaxone, amoxicillin-clavulanate, cefpodoxime)
    • +1Switches to oral therapy since he can take oral medications
    • +2Total duration 7 days
    • -3Escalates to a broader agent such as meropenem
    • -2Continues vancomycin
    • -2Extends therapy to 14 days
    Show answer

    Reference answer (1) Stop vancomycin: a negative nasal MRSA PCR has a high negative predictive value for MRSA pneumonia, and the sputum culture shows no MRSA. (2) Stop piperacillin-tazobactam and de-escalate to a narrow agent active against beta-lactamase-positive H. influenzae: ceftriaxone 1-2 g daily, or go directly to oral amoxicillin-clavulanate 875/125 mg twice daily since he can take oral medications (other suitable narrow oral agents such as cefpodoxime are acceptable). (3) Antipseudomonal coverage is no longer needed. (4) Total duration 7 days counted from the start of effective therapy. (5) Reassess if he deteriorates.

    Source 2016 IDSA/ATS Guideline for Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia; 2019 ATS/IDSA Guideline for Diagnosis and Treatment of Adults with Community-acquired Pneumonia (nasal MRSA PCR for de-escalation, extrapolated to HAP)

  28. AMS-028Short answerInfectious diseasesAdvanced

    A 74-year-old man hospitalized for pneumonia developed diarrhea and was diagnosed with C. difficile infection. Today he deteriorates: BP 82/50 mmHg requiring norepinephrine, lactate 4.2 mmol/L, WBC 32,000/µL, marked abdominal distension with absent bowel sounds. Abdominal CT shows diffuse colonic wall thickening and paralytic ileus without free air. He has completed his pneumonia course. Give the antibiotic regimen and other key management.

    Rubric

    • +2Identifies fulminant CDI
    • +2Oral/NG vancomycin 500 mg four times daily (fidaxomicin does not earn this point)
    • +2Adds rectal vancomycin because of ileus
    • +2Adds IV metronidazole
    • +2Requests early surgical consultation
    • +1Gives at least two of: stopping other unnecessary antibiotics, avoiding antimotility agents/opioids, sepsis support
    • -3Substitutes oral metronidazole or IV vancomycin for oral/NG vancomycin
    • -2Uses loperamide or another antimotility agent
    Show answer

    Reference answer This is fulminant CDI (hypotension/shock, ileus). (1) Vancomycin 500 mg four times daily by mouth or nasogastric tube; (2) because of ileus, add rectal vancomycin retention enemas (500 mg in 100 mL normal saline every 6 hours); (3) plus IV metronidazole 500 mg every 8 hours; (4) early surgical consultation to evaluate subtotal colectomy or diverting loop ileostomy with colonic lavage; (5) stop unnecessary antibiotics and avoid opioids and antimotility agents such as loperamide; (6) sepsis care with fluids and vasopressors, and close monitoring for perforation or toxic megacolon.

    Source 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children; 2021 IDSA/SHEA Focused Update Guideline on Management of Clostridioides difficile Infection in Adults

  29. AMS-029Short answerInfectious diseasesAdvanced

    A 26-year-old woman at 20 weeks' gestation has prenatal syphilis serology with RPR 1:32 and a reactive TP-PA, plus a copper-colored macular rash on the palms and soles; she is diagnosed with secondary syphilis. She had anaphylactic shock after an injection of penicillin in the past. Per the CDC 2021 STI treatment guidelines, give the treatment plan and key precautions.

    Rubric

    • +4Desensitizes, then gives benzathine penicillin G 2.4 million units IM
    • +2States there is no reliable alternative to penicillin in pregnancy
    • +1Mentions the Jarisch-Herxheimer reaction and its fetal/uterine risk
    • +1Fetal ultrasound at ≥20 weeks without delaying treatment
    • +1Partner notification and treatment, or HIV testing
    • -3Uses doxycycline or tetracycline
    • -3Substitutes azithromycin, erythromycin, ceftriaxone or a non-benzathine penicillin preparation (e.g., Bicillin C-R) for benzathine penicillin G
    • -3Gives penicillin with neither desensitization nor a negative penicillin skin test
    Show answer

    Reference answer (1) Penicillin is the only therapy proven to treat fetal infection in pregnancy; there is no reliable alternative. A penicillin-allergic pregnant woman should be desensitized in a setting equipped for resuscitation and then treated with benzathine penicillin G 2.4 million units IM (single dose for early syphilis; some experts give a second dose 1 week later in pregnancy). (2) Doxycycline/tetracycline is contraindicated; erythromycin and azithromycin do not reliably treat the fetus and ceftriaxone data are insufficient - none is an alternative. (3) At ≥20 weeks, ultrasound for fetal syphilis is recommended but must not delay treatment; counsel about and monitor for the Jarisch-Herxheimer reaction, which can precipitate contractions or fetal heart rate abnormalities. (4) Test for HIV and other STIs; notify and treat partners; repeat nontreponemal titers at 28-32 weeks and at delivery.

    Source CDC Sexually Transmitted Infections Treatment Guidelines, 2021

  30. AMS-030Short answerInfectious diseasesIntermediate

    A previously healthy 32-year-old man has community-acquired perforated appendicitis with a localized abscess. He has undergone laparoscopic appendectomy with abscess drainage, and source control is adequate. No septic shock, no recent hospitalization or antibiotic exposure. Give the empiric antibiotic choice (including agents to avoid and why) and duration.

    Rubric

    • +3Chooses an appropriate narrow regimen such as ceftriaxone plus metronidazole or ertapenem (other guideline-listed regimens, e.g., cefoxitin, or a fluoroquinolone plus metronidazole where local E. coli susceptibility is high, also earn credit)
    • +2Says to avoid ampicillin-sulbactam or clindamycin and gives the resistance reason
    • +2About 4 days of therapy after source control
    • +1States routine coverage of Pseudomonas, enterococci or Candida is unnecessary
    • -3Routinely uses an antipseudomonal carbapenem (meropenem/imipenem) or piperacillin-tazobactam (ertapenem is not penalized)
    • -2Routinely adds antifungal or anti-enterococcal therapy
    • -2Treats for 10-14 days or until the WBC normalizes
    Show answer

    Reference answer (1) Mild-to-moderate community-acquired complicated intra-abdominal infection needs coverage of Enterobacterales and anaerobes: ceftriaxone (or cefotaxime) plus metronidazole, or ertapenem monotherapy (guided by local community ESBL rates). Do not routinely use antipseudomonal agents such as piperacillin-tazobactam or meropenem, and do not cover enterococci or Candida. (2) Avoid ampicillin-sulbactam (high community E. coli resistance) and avoid clindamycin for anaerobic coverage (high Bacteroides fragilis resistance). (3) With adequate source control, a fixed course of about 4 days after the procedure (STOP-IT) is enough; there is no need to wait for normal WBC or temperature, and oral step-down is acceptable once eating.

    Source SIS 2017 Revised Guidelines on the Management of Intra-abdominal Infection; STOP-IT trial (Sawyer et al., NEJM 2015); SIS/IDSA 2010 Guidelines for Complicated Intra-abdominal Infection

Report